The biomarkers and studies discussed here involve patients with normal host defense mechanisms. The use of biomarkers in the evaluation of children with significant comorbidities has not been well defined, and these patient populations were, almost always, intentionally excluded from the studies discussed here.
To read the rest of this section, choose one of the options below.